Holen Sie sich die Stockscreener-App
4.41
5.77%
-0.27
Handel nachbörslich:
4.41
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
1 Healthcare Stock Worth Your Attention and 2 We Brush Off - Yahoo Finance UK
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call - Yahoo Finance
Citi Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Evolent Health (NYSE:EVH) Shares Up 10%What's Next? - marketbeat.com
Evolent Health (EVH) Q2 2026 Earnings Call Transcript - The Globe and Mail
Evolent Health rated Buy despite heavy debt and losses, betting on strong growth by 2027. - Pluang
Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming (EVH) - Seeking Alpha
Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH) - The Globe and Mail
Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH - marketbeat.com
EVH Maintained by Truist Securities -- Price Target Lowered to $6.00 - GuruFocus
Truist Financial Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - marketbeat.com
Truist Financial Maintains Evolent Health(EVH.US) With Hold Rating, Cuts Target Price to $6 - Moomoo
Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Australia
Truist cuts Evolent Health stock price target on execution risks - Investing.com
Truist Securities Adjusts Price Target on Evolent Health to $6 From $7, Keeps Hold Rating - marketscreener.com
Evolent Health Shares Rise After Citigroup Upgrade - marketscreener.com
EVH Upgraded by Citigroup -- Price Target Lowered to $6.00 - GuruFocus
EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget
Evolent Health, Inc. (EVH) Stock Analysis: A Healthcare Tech Player with a 46% Potential Upside - DirectorsTalk Interviews
Evolent Health Price Target Cut to $6.00/Share From $7.00 by Canaccord Genuity - Moomoo
Citi Upgrades Evolent Health(EVH.US) to Buy Rating, Cuts Target Price to $6 - Moomoo
Evolent Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:EVH) 2026-08-10 - Seeking Alpha
EVH Looks 60.0% Undervalued on GF Value™ Despite Profitability C - GuruFocus
Canaccord cuts Evolent Health stock price target on margin outlook By Investing.com - Investing.com Nigeria
EVH Maintained by Canaccord Genuity -- Price Target Lowered to $6.00 - GuruFocus
Canaccord cuts Evolent Health stock price target on margin outlook - Investing.com
Evolent Health (NYSE:EVH) Given New $6.00 Price Target at Canaccord Genuity Group - marketbeat.com
Evolent Health Is Maintained at Buy by Canaccord Genuity - Moomoo
Why (EVH) Price Action Is Critical for Tactical Trading - Stock Traders Daily
EVH Q2 2026 Deep Dive: Oncology Suite and AI Automation Drive Growth Amid Membership Headwinds - finance.yahoo.com
Evolent Health (NYSE:EVH) Announces Quarterly Earnings Results - MarketBeat
A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $5 to $6 - Moomoo
Evolent Health (NYSE:EVH) Shares Cross Below 200 Day Moving AverageTime to Sell? - MarketBeat
Evolent Health Q2 Earnings Call Highlights - Yahoo Finance
Evolent Health (EVH) Stock Rebounds As Growth Momentum Confronts Losses - Sahm
Evolent Health Inc (EVH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BMO Capital Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $6 - Moomoo
William Blair Maintains Evolent Health(EVH.US) With Buy Rating - Moomoo
Evolent Health Inc (EVH) (Q2 2026) Earnings Call Highlights: Rev - GuruFocus
Evolent Health, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Evolent Health beats Q2 2026 estimates, shares jump - Investing.com Canada
Evolent Health Q2 2026 slides: revenue surges 32%, margins compress - Investing.com
Evolent Health Inc earnings beat by $0.03, revenue topped estimates - Investing.com
Evolent Health Inc (EVH) Reports Q2 Earnings -- EPS Misses Estim - GuruFocus
Evolent Health, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Compared to Estimates, Evolent Health (EVH) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Evolent Health, Inc. 2026: Revenue $652.52M, EPS ($0.25) — 10-Q Summary - TradingView
Why is Evolent Health stock surging today? - Investing.com
Why is Evolent Health stock surging today? By Investing.com - Investing.com Canada
Evolent Health, Inc. Provides Earning Guidance for the Year 2027 - marketscreener.com
Evolent Health, Inc. Raises Revenue Guidance for the Full Year 2026 - marketscreener.com
Evolent Health (EVH) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Q2 2026 Evolent Health, Inc. Earnings Call Transcript - GuruFocus
Evolent Health (NYSE:EVH) Reports Bullish Q2 CY2026, Stock Jumps 18.2% - Barchart.com
Evolent Health Q2 revenue beats expectations - TradingView
Evolent Health Q2 Revenue Rises to $652.5 Million - Quiver Quantitative
Evolent Health: Q2 Earnings Snapshot - Barchart.com
Evolent Health posts Q2 2026 revenue $652.5M, Adjusted EBITDA $28.1M - TradingView
BRIEF-Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million - TradingView
Press Release: Evolent Announces Second Quarter 2026 Results - 富途牛牛
Evolent Health Earnings: What To Look For From EVH - Barchart.com
Evolent Health, Inc. expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Gabelli Funds LLC Decreases Stake in Evolent Health, Inc $EVH - MarketBeat
Evolent Health (EVH) to Release Earnings on Thursday - MarketBeat
Evolent Health Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
2.27%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):